Optimising Your Pharmacovigilance Activities in Clinical Trials

Hosted By: Andrea Charles
01/10/2011
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Pharmacovigilance is an important and integral part of clinical research. Elie Magdalani, Regional Manager, Medical and Pharmacovigilance Affairs Egypt and North Africa, Ranbaxy Egypt, joins Andrea Charles from Pharma IQ, to talk about how we can ensure the proactive and proportionate collection of high-quality data relevant to the safety of medicines through risk management and structured data collection. Magdalani discusses how can we effectively manage risk throughout the lifecycle of a product and what strategies pharmaceutical companies are employing to optimise their drug safety teams and pharmacovigilance activities.


 

EVENTS OF INTEREST

Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018